Onyx | February 04, 2021
Onyx Technology LLC is extremely pleased to announce today the release of SAFHIR 3, the only truly foundational health data interoperability platform in the market. Accessible to all health plans, SAFHIR 3 instantly enables compliance with the Office of the National Coordinator for Health Information Technology (ONC) and the Centers for Medicare and Medicaid Services (CMS)) data sharing rules while concurrently allowing health plans to consume their data exchange to make actionable data that advances the superiority of care while dipping charges.
“With SAFHIR 3, we are providing health plans the chance to not just be compliant with the data sharing guidelines, but also completely understand the worth of that data exchange, capture the information in that data and make a foundational set-up for this new age of health data interoperability,” said CEO of Onyx, Susheel Ladwa.
Built in partnership with Microsoft to exclusively deliver the scalability and safety of the Azure stack, SAFHIR 3 offers out-of-the box healthcare data interoperability for America’s health payers and providers. The platform allows safe connections among payers, providers and patients and is built on the team’s knowledge in creation of the Blue Button 2.0 API for the Centers for Medicare and Medicaid Services which offers secure, FHIR-based data distribution to over 50 million recipients.
“The SAFHIR 3 platform delivers a true basis for a payer’s interoperability requirements,” said Edward Yurcisin, Onyx Technology’s Chief Product Officer. “This platform is constructed on top of Microsoft’s Azure API for FHIR and allows the exchange of information using any HL7® Implementation Guide always. SAFHIR 3 not only allows payers to meet their governing requirements, but to also map, combine, and use data to deliver qualitatively superior care while dipping the rate of that care.”
About Onyx Technology LLC
Onyx Technology, LLC is a provider of healthcare interoperability solutions. Onyx, a NewWave company, arose from work with CMS in starting the nation’s first nationwide FHIR-based API, Blue Button 2.0. Building on this knowledge and know-how, Onyx has joined with Microsoft to build the industry’s important platform for FHIR-based interoperable exchange. Concentrated on standards based, interoperable technologies that confirm safety, confidentiality, and the distribution of the correct information to the correct place at the accurate time, Onyx is the professional in enabling our customers to gather the highest value from their contribution in the future healthcare eco-system.
H1 | September 03, 2021
H1, which provides the largest global healthcare platform connecting the healthcare ecosystem, announced today that it has launched H1 Trial Landscape, the first solution that not only helps pharma and life sciences companies determine the required clinical experience levels for their clinical trials, but also enables them to find the best patient segments to improve inclusivity, retention and recruitment for successful trials.
Studies have shown that more than 80 percent of trials fail to enroll patients in a timely manner, causing delays in the trial process. By providing powerful data insights, H1 can reverse this trend to empower companies to create a healthier future for patients across the globe.
H1 Trial Landscape can help companies:
Lower study startup costs by planning more efficiently
Understand the site and investigator clinical trial landscape
Make better partnership choices for studies based on patient needs and organizational interest
Improve patient retention and reduce risk of patient recruitment failure
Simplify internal staff training with one platform that evolves with a drug’s lifecycle
H1 has also pioneered a path forward for pharma and life sciences by partnering with physicians and organizations to map relevant trends within clinical trial diversity and inclusion. This new data comes as a response to new FDA guidance around enhancing diversity in clinical trials and encouraging inclusivity in medical product development, given life sciences companies are now required to report on the diversity of their trial patient populations.
“H1 Trial Landscape can help a company complete feasibility much more quickly, often in hours, instead of weeks,” said Ariel Katz, cofounder and CEO of H1. “And it’s the only such solution that specifically addresses and segments potential diverse patient populations for clinical trials.”
One of the first companies to utilize H1 Trial Landscape is a leader in data-driven and innovative clinical trials, TrialSpark, which runs clinical trials in partnership with multiple pharma and life sciences companies. "H1’s solutions have helped us greatly accelerate proposal development as well as the trial planning phase to help us find KOLs and identify high quality potential sites to advance our recruitment initiatives,” said Leslie Saltzman, Senior Medical Director, TrialSpark. “Not only does H1’s mission really resonate with our team, but we've appreciated the ability to partner to help bring diversity to clinical trials, ultimately increasing access to a broader population of patients. Anything that helps us advance clinical research is a huge win, which makes H1 a no-brainer for us.”
Powered by H1’s existing HCP Universe platform which consists of industry leading site and investigator data, H1 Trial Landscape is available as an add-on to the H1 HCP universe solution. Learn more at H1 Trial Landscape.
H1 provides the largest global healthcare platform to help life sciences companies, hospitals, academic medical centers and health systems connect with providers, find clinical research, locate industry experts, and benchmark their organization. As the trusted source of information on healthcare professionals and institutions, H1 connects the entire healthcare ecosystem through real-time data and clinical findings.
FUTURE OF HEALTHCARE
Hispanic Health Coalition of GA | June 06, 2022
On June 5th, the Hispanic Coalition of Georgia announced that it is collaborating with HIA Technologies to develop HIA TopicsTM, an education platform that will be used to address misinformation, boost engagement, and increase health literacy.
The strategic expansion will address the issues of the Hispanic/Latino community as well as other minorities, underprivileged and economically challenged groups. HIA TOPICS leverages over 20 years of research in human-computer interaction, and advanced AI technologies.
"The HHCGA has long regarded education as a critical strategic component in the quest to promote awareness and facilitate access to healthcare services and available benefits. By partnering with HIA, the HHCGA can now deliver a library of healthcare topics, sourced from known and respected subject matter experts to the Hispanic/Latino community. HIA TOPICS represents an extraordinary opportunity for underserved communities to have answers to health questions and to do so in an interactive virtual learning environment."
Shirley E. "Bella," Borghi, HHCGA Executive Director
HIA TOPICS will enable clinicians to access a physician-authored library of health topics. Digital agents will then host an interactive session that will allow patients to ask questions and get answers through a physician-controlled AI technology.
The HHCGA has long regarded education as a critical strategic component in the quest to promote awareness and facilitate access to healthcare services and available benefits. By partnering with HIA, the HHCGA can now deliver a library of healthcare topics, sourced from known and respected subject matter experts to the Hispanic/Latino community. HIA TOPICS represents an extraordinary opportunity for underserved communities to have answers to health questions, and to do so in an interactive virtual learning environment."
CEO Vacit Arat